SCPC Calls for Immediate Congressional Action to Fix Broken LTC Pharmacy Payment Model as More Drugs Become Subject to Mandatory Medicare Price Negotiations
The Senior Care Pharmacy Coalition (SCPC), the leading national voice for the long-term care (LTC) pharmacy community, released a statement on the newly released Medicare drug price negotiations from the Biden Administration on the next 15 drugs:
“Today, the Biden administration announced the next 15 drugs that will be subject to Medicare price negotiations, which include another 10 medications often utilized by patients in long-term care (LTC). This decision means the majority of the 25 drugs selected so far – 8 of 10 in 2026 and 10 of 15 in 2027 – will have a direct and substantial impact on the ability of LTC pharmacies to continue providing essential care services, underscoring the urgent need for Congress to act. Lawmakers must address the unintended consequences of this new policy and the severe impact it will have on both LTC pharmacies and the unique patient population they serve.
“The Part D pharmacy payment model is broken, forcing LTC pharmacies to dispense medications significantly below their own costs while allowing Part D Plans and PBMs to reap massive profits at their expense.
“The first round of 10 drugs subject to Medicare price negotiations already included eight medications frequently used by patients in long-term care. Adding another 10 to the list under the current Medicare payment model will only further exacerbate the dire situation facing LTC pharmacies and patients. Seniors in nursing homes and assisted living facilities amongst other long-term care settings depend on LTC pharmacies to provide 24/7 essential pharmacy services –longstanding services now facing disruption, particularly for small pharmacies serving rural areas.
“SCPC and its members having been sounding the alarm on this critical issue through the organization’s Save Senior Rx Care campaign. Congress must now act before it’s too late and pass corrective action before the first round of drug prices takes effect on January 1, 2026,” said Alan Rosenbloom, President and CEO of SCPC.
More information on the impact of Medicare drug price negotiations on LTC pharmacies and the solution Congress must adopt are available at https://seniorcarepharmacies.org/policy-priorities/.
###
Recent Posts
-
Pharmacy Community Stands Together to Protect Seniors and Prevent a Long-Term Care Crisis
The Senior Care Pharmacy Coalition (SCPC), representing the nation’s long-term care pharmacies, the American Society of Consultant Pharmacists (ASCP), representing pharmacists and pharmacies dedicated to managing medications for older adults and medically complex patients, and the National Community Pharmacists Association (NCPA), representing community pharmacists nationwide, stand united in support of immediate action—whether through legislation or […]
-
Rep. Beth Van Duyne: Congress can save seniors’ access to medications before it’s too late
Seniors in nursing homes across the country depend on round-the-clock care and medications, perhaps more than any other American patient population. In turn, the nursing homes and assisted living facilities that care for them depend on a small number of specialized long-term care (LTC) pharmacies to ensure their patients have access to the prescription meds they need.
-
Bill Aims to Offset Reimbursement Losses for Long-Term Care Pharmacies Catering to Nursing Homes
Starting in January, falling prices for costly drugs may strain long-term care pharmacies, but proposed legislation backed by advocacy groups aims to subsidize some of this loss. And nursing home advocacy groups are among those urging Congress to pass the Preserving Patient Access to Long-Term Care Pharmacies Act.
Stay in the Know
Get the latest news and updates on issues impacting the long-term pharmacy community.